2 unchanged sentences
During the quarter ended
−Removed: June 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading
−Removed: arrangements (in each case, as defined in Item 408(a) of Regulation S-K).
+Added: September 30, 2025, no director or Section 16 officer adopted or terminated any Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading
+Added: arrangements (in each case, as defined in Item 408(a) of Regulation S-K), except as disclosed below.
+Added: On September 19, 2025 , Joana
+Added: Goncalves , our Chief Medical Officer , adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c)
+Added: for the sale of up to 151,000 shares of our common stock over a period ending upon the earlier of when all shares under the plan are sold,
+Added: or June 30, 2027 , subject to certain conditions.
+Added: On September 19, 2025 , Laura Sandler , our Chief Operating Officer ,
+Added: adopted a Rule 10b5-1 trading arrangement intended to satisfy the affirmative defense of Rule 10b5-1(c) for the sale of up to 33,000 shares
+Added: of our common stock over a period ending upon the earlier of when all shares under the plan are sold, or December 31, 2026 , subject to
+Added: certain conditions.
The exhibits filed or furnished as part of this
19 unchanged sentences
September 13, 2024
+Added: Form of Pre-Funded Warrant, dated September 19, 2025.
+Added: September 22, 2025
Paruka Warrant, dated December 31, 2024
+Added: Securities Purchase Agreement, dated September 17, 2025, by and between Oruka Therapeutics, Inc.
+Added: and each purchaser identified on Annex A thereto.
+Added: September 22, 2025
+Added: Form of Registration Rights Agreement, dated September 17, 2025 .
+Added: September 22, 2025
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or 15d-14(a) promulgated under the Securities Exchange Act of 1934
17 unchanged sentences
Oruka Therapeutics, Inc.
−Removed: August 11, 2025
+Added: November 12, 2025
/s/ Lawrence Klein
2 unchanged sentences
(Principal Executive Officer)
−Removed: August 11, 2025
+Added: November 12, 2025
/s/ Arjun Agarwal
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.